Author

Hiroshi Tanabe

2 papers indexed here

We haven’t gathered this author’s papers yet. Follow them and we’ll fetch their work.

Not the right person? Other researchers publish under this name.

Review Open access Sep 2026

Guidelines for the treatment of ovarian cancer, fallopian tube cancer, and primary peritoneal cancer: 2025 edition by the Japan Society of Gynecologic Oncology.

To present the 2025 revision of the Japan Society of Gynecologic Oncology Clinical Practice Guidelines for the treatment of ovarian, fallopian tube, and primary peritoneal cancers, which incorporates recent advances in surgical strategies, molecular diagnostics, and maintenance therapies within the context of the Japan...

T. Shoji, Tsukasa Baba, Yoichi Kobayashi et al. · Journal of Gynecologic Oncol... · 1 citation

Open access Sep 2026

Changes and clinical impact of HER3 and ERBB3 expression in primary and recurrent ovarian cancer.

OBJECTIVE Human epidermal growth factor receptor (HER) 3, encoded by the ERBB3 gene, transduces signals most effectively when dimerized with HER2. Although HER3 protein expression has been considered a poor prognostic factor in ovarian cancer, limited data exist on changes in HER3 protein expression and ERBB3 messenger...

K. Yokosu, Riu Yamashita, Satoshi Fujii et al. · Journal of Gynecologic Oncol... · 0 citations